Earnings · China A-shares
Hefei Lifeon Pharmaceutical Co., Ltd. Class A (003020) earnings
Hefei Lifeon Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit -9.86% year on year, -19.29% excluding one-off items. Wave Radar's earnings-quality score is 95 of 100 (Sound). The stock moved -4.40% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -9.86%
- Excl. one-offs YoY
- -19.29%
- Net profit QoQ
- -60.67%
- Result
- Neutral
- Quality score
- 95
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -4.27% | — |
| 3 days | -4.40% | — |
| 7 days | -2.20% | — |
| 14 days | -7.70% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -3.31%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥109.01M | -9.86% | -19.29% | -8.76% | 0.48 | 5.89% | -4.40% | — | — |
| 2026 interim report | 2026-08-29 | ¥88.21M | -2.24% | -18.07% | -6.58% | 0.39 | 4.78% | -2.95% | -13.83% | -4.50% |
| 2026 Q1 report | 2026-04-28 | ¥35.29M | -7.74% | +6.04% | -0.87% | 0.19 | 1.93% | -2.40% | -34.26% | -33.64% |
| 2025 annual report | 2026-04-28 | ¥165.19M | +2.86% | -15.78% | +2.33% | 0.87 | 9.26% | -2.40% | -34.26% | -33.64% |
| 2025 Q3 report | 2025-10-30 | ¥120.94M | +1.65% | -20.23% | -3.95% | 0.64 | 6.79% | +2.24% | -2.31% | +2.44% |
| 2025 interim report | 2025-08-26 | ¥90.23M | +16.53% | -9.68% | -4.80% | 0.47 | 5.09% | -16.88% | -28.00% | -29.68% |
| 2025 Q1 report | 2025-04-22 | ¥38.25M | +25.94% | +11.28% | +7.98% | 0.20 | 2.18% | +4.51% | -23.68% | -26.54% |
| 2024 annual report | 2025-04-22 | ¥160.60M | -29.15% | -20.05% | -20.11% | 0.84 | 9.33% | +4.51% | -23.68% | -26.54% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.